Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × SCLC × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 230 Neoplasms 160 Breast Neoplasms 145 Colorectal Neoplasms 98 Neoplasm Metastasis 96 Prostatic Neoplasms 89 Multiple Myeloma 85 Ovarian Neoplasms 81 Recurrence 76 Lung Neoplasms 75 Squamous Cell Carcinoma of Head and Neck 60 Pancreatic Neoplasms 53 Stomach Neoplasms 52 Melanoma 52 Endometrial Neoplasms 52 Urinary Bladder Neoplasms 51 Lymphoma, Non-Hodgkin 50 Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Large B-Cell, Diffuse 47 Carcinoma, Hepatocellular 44 Leukemia, Myeloid, Acute 43 Carcinoma, Renal Cell 41 Small Cell Lung Carcinoma 40 Triple Negative Breast Neoplasms 36 Parkinson Disease 4, Autosomal Dominant Lewy Body 33 Glioblastoma 33 Uterine Cervical Neoplasms 31 Lymphoma, Follicular 31 Esophageal Neoplasms 29 Carcinoma, Transitional Cell 29

Interventions

atezolizumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2026-04-03

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡